elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34308495-85B73CEC-3685-4D79-B355-3850A5ACF2D5
Q34308495-85B73CEC-3685-4D79-B355-3850A5ACF2D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34308495-85B73CEC-3685-4D79-B355-3850A5ACF2D5
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
P2860
Q34308495-85B73CEC-3685-4D79-B355-3850A5ACF2D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34308495-85B73CEC-3685-4D79-B355-3850A5ACF2D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5d358620219dbca40993bd3cd99d9d66d0cb0e4
P2860
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan